BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 17229604)

  • 21. Treatment of genital warts with an immune-response modifier (imiquimod).
    Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials.
    Werner RN; Westfechtel L; Dressler C; Nast A
    Sex Transm Infect; 2017 Dec; 93(8):543-550. PubMed ID: 28637906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts--results of an open-label, multicentre Phase IIIB trial.
    Garland SM; Sellors JW; Wikstrom A; Petersen CS; Aranda C; Aractingi S; Maw RD;
    Int J STD AIDS; 2001 Nov; 12(11):722-9. PubMed ID: 11589811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
    Gilson RJ; Shupack JL; Friedman-Kien AE; Conant MA; Weber JN; Nayagam AT; Swann RV; Pietig DC; Smith MH; Owens ML
    AIDS; 1999 Dec; 13(17):2397-404. PubMed ID: 10597781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Topical imiquimod for the treatment of anogenital warts in an infant].
    Skowron C; Raoulx M; Skowron F
    Ann Dermatol Venereol; 2010 Oct; 137(10):622-5. PubMed ID: 20932441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of cryotherapy to imiquimod 5% in the treatment of anogenital warts.
    Stefanaki C; Katzouranis I; Lagogianni E; Hadjivassiliou M; Nicolaidou E; Panagiotopoulos A; Anyfantakis V; Bethimoutis G; Rallis E; Antoniou C; Katsambas A
    Int J STD AIDS; 2008 Jul; 19(7):441-4. PubMed ID: 18574113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of daily self-application of imiquimod 3.75% cream in adult patients with external anogenital warts.
    Wu J; Feldman R; Barry GT; Kulp J; Adams MP; Levy S
    J Clin Pharmacol; 2012 Jun; 52(6):828-36. PubMed ID: 22232733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive condyloma acuminata treated with imiquimod 5% cream: a case report.
    Cox JT
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():51-4. PubMed ID: 14616817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
    Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
    J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vagarious successful treatment of recalcitrant warts in combination with CO2 laser and imiquimod 5% cream.
    Zeng Y; Zheng YQ; Wang L
    J Cosmet Laser Ther; 2014 Dec; 16(6):311-3. PubMed ID: 25148409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intralesional injection of Mycobacterium w vaccine vs imiquimod, 5%, cream in patients with anogenital warts: a randomized clinical trial.
    Kumar P; Dar L; Saldiwal S; Varma S; Datt Upadhyay A; Talwar D; Sharma VK; Verma KK; Dwivedi SN; Raj R; Gupta S
    JAMA Dermatol; 2014 Oct; 150(10):1072-8. PubMed ID: 25103148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5% topical imiquimod tolerance in transplant recipients.
    Ben M'barek L; Mebazaa A; Euvrard S; Frances C; Thervet E; Morel P; Menasché S; Legendre C; Lebbe C
    Dermatology; 2007; 215(2):130-3. PubMed ID: 17684375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children.
    Grussendorf-Conen EI; Jacobs S
    Pediatr Dermatol; 2002; 19(3):263-6. PubMed ID: 12047649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Topical imiquimod cream in the treatment of external anogenital warts: personal experience].
    Senatori R; Dionisi B; Lippa P; Inghirami P
    Minerva Ginecol; 2003 Dec; 55(6):541-6. PubMed ID: 14676745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imiquimod in the treatment of cutaneous warts: an evidence-based review.
    Ahn CS; Huang WW
    Am J Clin Dermatol; 2014 Oct; 15(5):387-99. PubMed ID: 25186654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical imiquimod for recalcitrant facial flat warts.
    Schwab RA; Elston DM
    Cutis; 2000 Mar; 65(3):160-2. PubMed ID: 10738635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anogenital warts: a new way of solving the common problem of urology (results of long-term follow-up)].
    Protasov AD; Lipatov IS; Kostinov MP; Tezikov YV; Shmitko AD; Pakhomov DV; Blagovidov DA; Zhestkov AV; Ryzhov AA; Vekhova EV
    Urologiia; 2016 Nov; (5):47-51. PubMed ID: 28248020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical imiquimod treatment of human papillomavirus in a patient with human immunodeficiency virus.
    Gilbert J; Drehs MM; Weinberg JM
    Acta Derm Venereol; 2001; 81(4):301-2. PubMed ID: 11720183
    [No Abstract]   [Full Text] [Related]  

  • 39. New patient-applied therapy for anogenital warts is rated favourably by patients.
    O'Mahony C; Law C; Gollnick HP; Marini M
    Int J STD AIDS; 2001 Sep; 12(9):565-70. PubMed ID: 11516364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of anogenital warts in children with topical 0.05% podofilox gel and 5% imiquimod cream.
    Moresi JM; Herbert CR; Cohen BA
    Pediatr Dermatol; 2001; 18(5):448-50; discussion 452. PubMed ID: 11737696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.